Actively Recruiting
Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
Led by Group for Research in Adult Acute Lymphoblastic Leukemia · Updated on 2026-02-25
500
Participants Needed
1
Research Sites
539 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.
CONDITIONS
Official Title
Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
GRAALL
Pierre-Bénite, France, 69310
Actively Recruiting
Research Team
A
Aline SCHMIDT, MD/PhD
CONTACT
V
Véronique LHERITIER, Central coordination
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here